KM Plotter analysis revealed a significantly poor (p = 6.4x10-10) prognosis in HCC patients having low levels of CCL23, with a median survival of 27.57 months vs. 82.87 months (Figure 2A). The gene discussed is CCL23; the disease is hepatocellular carcinoma.